NO984446L - FremgangsmÕte for behandling av smerte - Google Patents

FremgangsmÕte for behandling av smerte

Info

Publication number
NO984446L
NO984446L NO984446A NO984446A NO984446L NO 984446 L NO984446 L NO 984446L NO 984446 A NO984446 A NO 984446A NO 984446 A NO984446 A NO 984446A NO 984446 L NO984446 L NO 984446L
Authority
NO
Norway
Prior art keywords
treating pain
procedure
olanzapine
mammal
administering
Prior art date
Application number
NO984446A
Other languages
English (en)
Norwegian (no)
Other versions
NO984446D0 (no
Inventor
David R Helton
Mary J Kallman
Harlan E Shannon
Daniel E Womer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984446D0 publication Critical patent/NO984446D0/no
Publication of NO984446L publication Critical patent/NO984446L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
NO984446A 1996-03-25 1998-09-24 FremgangsmÕte for behandling av smerte NO984446L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1413196P 1996-03-25 1996-03-25
US1415396P 1996-03-25 1996-03-25
US1413396P 1996-03-25 1996-03-25
PCT/US1997/004626 WO1997035583A1 (en) 1996-03-25 1997-03-24 Method for treating pain

Publications (2)

Publication Number Publication Date
NO984446D0 NO984446D0 (no) 1998-09-24
NO984446L true NO984446L (no) 1998-11-25

Family

ID=27360028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984446A NO984446L (no) 1996-03-25 1998-09-24 FremgangsmÕte for behandling av smerte

Country Status (14)

Country Link
US (1) US6258807B1 (zh)
EP (1) EP0910381A4 (zh)
JP (1) JP2001517202A (zh)
CN (1) CN1219878A (zh)
AU (1) AU721338B2 (zh)
BR (1) BR9708246A (zh)
CA (1) CA2248873A1 (zh)
CZ (1) CZ298198A3 (zh)
EA (1) EA199800866A1 (zh)
IL (1) IL126064A0 (zh)
NO (1) NO984446L (zh)
PL (1) PL329217A1 (zh)
WO (1) WO1997035583A1 (zh)
YU (1) YU42298A (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller
CN1726037B (zh) * 2002-11-26 2010-05-05 艾利斯达医药品公司 抗精神病药用于制备通过吸入传送治疗头痛的药物中的应用
PT1567164E (pt) 2002-11-26 2009-03-31 Alexza Pharmaceuticals Inc Utilização de loxapina para o fabrico de um medicamento para o tratamento da dor
CA2580730C (en) * 2003-09-25 2015-01-13 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
US7402777B2 (en) 2004-05-20 2008-07-22 Alexza Pharmaceuticals, Inc. Stable initiator compositions and igniters
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
EA201590048A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение оланзапина у животных
US20150216206A1 (en) 2012-07-31 2015-08-06 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Method for increasing meat and milk production
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994924A (en) * 1975-11-04 1976-11-30 American Cyanamid Company 4,5,6,7-Tetra hydro-7-oxobenzo(B)thien-4-yl isocyanate and isothiocyanate
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
NO305125B1 (no) * 1992-05-29 1999-04-06 Lilly Industries Ltd Farmas°ytiske forbindelser
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
US5605911A (en) * 1995-01-31 1997-02-25 Washington University Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
EA000769B1 (ru) * 1996-03-25 2000-04-24 Эли Лилли Энд Компани Способ лечения при боли, вызванной мигренью
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller

Also Published As

Publication number Publication date
CN1219878A (zh) 1999-06-16
NO984446D0 (no) 1998-09-24
JP2001517202A (ja) 2001-10-02
AU721338B2 (en) 2000-06-29
US6258807B1 (en) 2001-07-10
CA2248873A1 (en) 1997-10-02
CZ298198A3 (cs) 1999-06-16
IL126064A0 (en) 1999-05-09
PL329217A1 (en) 1999-03-15
YU42298A (sh) 1999-09-27
AU2340897A (en) 1997-10-17
WO1997035583A1 (en) 1997-10-02
EP0910381A1 (en) 1999-04-28
EA199800866A1 (ru) 1999-06-24
EP0910381A4 (en) 2002-10-09
BR9708246A (pt) 1999-07-27

Similar Documents

Publication Publication Date Title
PT934061E (pt) Isobutilgaba e seus derivados para o tratamento da dor
NO984446L (no) FremgangsmÕte for behandling av smerte
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
FI971290A0 (fi) Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
ATE267583T1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
MX9401294A (es) Derivados de azolona sustituida
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK1077683T3 (da) Antidepressiv behandling
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
NO984197L (no) FremgangsmÕte for behandling av autisme
NO20010390L (no) Behandling av angstsykdommer
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984190L (no) FremgangsmÕte for behandling av insomnia
SE9101341D0 (sv) New medicinal use
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
RU95106400A (ru) Способ предупреждения и лечения дифтерийных нейропатий в эксперименте

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application